Cargando…
Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide
BACKGROUND: RC-101, a cationic peptide retrocyclin analog, has in vitro activity against HIV-1. Peptide drugs are commonly prone to conformational changes, oxidation and hydrolysis when exposed to excipients in a formulation or biological fluids in the body, this can affect product efficacy. We aime...
Autores principales: | Sassi, Alexandra B, Bunge, Katherine E, Hood, Brian L, Conrads, Thomas P, Cole, Alexander M, Gupta, Phalguni, Rohan, Lisa C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199744/ https://www.ncbi.nlm.nih.gov/pubmed/21801426 http://dx.doi.org/10.1186/1742-6405-8-27 |
Ejemplares similares
-
The Formulated Microbicide RC-101 Was Safe and Antivirally Active Following Intravaginal Application in Pigtailed Macaques
por: Cole, Alexander M., et al.
Publicado: (2010) -
Inhibition of SARS-CoV-2 Infection by Human Defensin HNP1 and Retrocyclin RC-101
por: Kudryashova, Elena, et al.
Publicado: (2022) -
Retrocyclins and their activity against HIV-1
por: Penberthy, W. Todd, et al.
Publicado: (2011) -
The θ‐defensin retrocyclin 101 inhibits TLR4‐ and TLR2‐dependent signaling and protects mice against influenza infection
por: Prantner, Daniel, et al.
Publicado: (2017) -
Reawakening Retrocyclins: Ancestral Human Defensins Active Against HIV-1
por: Venkataraman, Nitya, et al.
Publicado: (2009)